Laurence Gladieff

7PUBLICATIONS
91CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsEconomic models and forecastingGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 15, 2026
ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial.

Guillaume Beinse, Valerie Taly, Alexandra Leary

|Dec 11, 2025
Benefit of plasma cystatin C for carboplatin individual dosing in a patient with spinal amyotrophy.

Matthieu Gracia, Sabrina Marsili, Julien Vintejoux

|Apr 14, 2025
Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair Genes.

Maximiliano Ribeiro-Guerra, Marie-Gabrielle Dondon, Séverine Eon-Marchais

|Oct 16, 2024
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors.

Brian M Slomovitz, David Cibula, Weiguo Lv

|Jul 20, 2024
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer.

Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri

|Oct 14, 2021
Pocket memo based on the ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma: definition of prognostic risk groups.

Manon Daix, Laurence Gladieff, Alejandra Martinez

Pageof 2

Frequent Collaborators

2 joint publications

Marie-Gabrielle Dondon

2 joint publications

Jean-Marc Limacher

2 joint publications

Laurence Venat-Bouvet

2 joint publications

Pascal Pujol